Arkadiusz Szatkowski

Articles translated into Polish by Arkadiusz Szatkowski

• Updates from the EHDN Meeting 2021
• Caution urged for the use of gene-editing technology CRISPR
• Huntington's disease therapeutics conference 2018 - day 1
• Huntington's disease therapeutics conference 2018 - day 2
• Huntington's disease therapeutics conference 2018 - day 3
• Success! ASO drug reduces levels of mutant protein in Huntington's disease patients
• Huntington's Disease Therapeutics Conference 2017 - Day 3
• Huntington's Disease Therapeutics Conference 2017 - Day 2
• Huntington's Disease Therapeutics Conference 2017 - Day 1
• FDA approves a new drug for symptoms of Huntington's disease
• Slightly long CAG repeats are more common than we thought
• Huntington's Disease Therapeutics Conference 2016 - day 1
• Huntington's Disease Therapeutics Conference 2016 - day 2
• Huntington's Disease Therapeutics Conference 2016 - day 3
• Harnessing the power of viruses to treat Huntington's disease
• Looking Past the Spin: Results from a Clinical Trial of Cysteamine
• Liftoff: First humans treated with gene silencing drugs for HD!
• HDBuzz primer: Clinical trial designs and phases
• Lighting the way: A new biomarker for Huntington’s disease
• Unlocking the Potential of Antibodies as a Therapy for Huntington’s Disease
• Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015
• Should we worry about a huntingtin invasion?
• Prana announces results of Reach2HD trial of PBT2 for Huntington's disease
• A starring role for astrocytes in Huntington's disease?
• New results bring BDNF therapies into focus
• 2CARE study of coenzyme Q for Huntington's disease ends in disappointment
• Could HD be caused by amino acid deficiency?
• NUB1: enhancing clearance to decrease mutant huntingtin
• HD mice provide a useful failure
• The brain in Huntington's disease: greater than the sum of its parts?
• Jumping genes: Huntington's disease protein invades brain transplants
• The sweet lowdown: Huntington's disease brains use sugar differently
• Sleep, cilia and HD
• Do dairy foods accelerate Huntington's disease?
• Could a new "jaw-dropping" breakthrough help treat Huntington's Disease?
• DNA shutdown proteins in Huntington's disease: More than meets the eye
• Splicing with danger: a new way of thinking about the harmful Huntington's disease protein
• Lost in translation? New insights into the making of the Huntington's disease protein
• The 'N17' region of huntingtin protein: an address label in Huntington's disease?
• A DNA repair protein modifies the stability of long CAG tracts in the Huntington's disease gene
• Start here!
• Can sad mice help treat Huntington's disease?
• Proposed Huntington's disease 'biomarker' is not useful, new study suggests
• Is a new technique set to revolutionize Huntington's disease genetic testing?
• Simple rules for a good night's sleep in Huntington's disease
• Gone fishing: protein network screen identifies new therapeutic targets in Huntington's disease
• The University of New Orleans has NOT discovered a cure for Huntington's disease
• HDBuzz Special Feature: Huntington's disease and sleep
• Liver changes in Huntington's disease patients suggest more 'whole body' research needed
• No surprises in published results from HART study of Huntexil for Huntington's disease
• Dyeing to prevent dying? Methylene blue beneficial in Huntington's disease mice
• 'Guard dog' proteins reveal surprising connections between Huntington's disease and other brain disorders
• Prana Biotech publishes Huntington's disease animal model data for PBT2
• Giving Huntington's disease the finger? Two teams report success for zinc-finger drugs in cells and mice
• Prominent Huntington's disease researcher "fabricated data" in grant applications
• Targeting oxidative stress in Huntington's Disease
• Calming down the immune system helps Huntington's disease mice
• Illuminating findings in blood cells from Huntington's disease patients
• HDBuzz Prize runner-up 2012: Fruit flies, faulty connections and Huntington's disease
• Of mice and men: using animal models to study Huntington's disease
• Shooting the messenger with single-stranded RNA gene silencing
• HDBuzz Prize winner 2012: Deep brain stimulation for HD
• Lithium with a twist gets second chance for HD
• High-power brain scans reveal sodium changes in HD
• Does the HD mutation affect children's growth?
• Mapping the neighborhood: huntingtin's new protein partners
• Phosphodiesterase inhibitors: new HD drugs entering trials soon
• 'Induced' stem cells make exciting advances
• Interview: CHDI's scientific team
• ASO gene silencing reaches further, lasts longer
• Closing the care gap: new guidelines for HD care
• What's the connection between Huntington's Disease and cancer?
• The HDBuzz Prize for young science writers
• Exercise increases cellular recycling
• New analysis suggests 'small' CAG length doesn't matter after all
• 2012 Therapeutics Conference: a retrospective
• Stem-cell neurons make the right connections
• Bone marrow transplantation in Huntington's Disease
• HDYO! Huntington's Disease Youth Organization goes live
• Double success for huntingtin RNAi gene silencing
• Turning down the volume with dantrolene helps HD mice
• 2011 - a year in Huntington's disease research
• Chinese Huntington’s Disease Network launched
• Safety trials add crucial piece to gene silencing jigsaw
• New antibody reveals dangerous parts of huntingtin protein
• Huntexil hits the headlines again
• HD World Congress 2011: a retrospective
• Melatonin treatment success in HD mice
• HD just got cilia
• HDAC inhibitors and a possible 'blood biomarker'
• Gene silencing takes a targeted step forward
• Stand By for Oz Buzz
• Ten golden rules for reading a scientific news story
• Stem cells and HD: past, present and future
• Coming soon from the HD World Congress: Oz Buzz!
• Therapeutics conference videos now online
• Cut-and-paste DNA: fixing mutations with 'genome editing'
• KMO inhibitor drug improves lifespan of Huntington's disease mice
• Caffeine, cannabis and caution
• What do sheep brains have to do with HD?
• Dimebon fails in late-stage human HD clinical trial
• 'Floating' gene-silencing drugs into the brain with exosomes
• Gene silencing for HD: the story so far
• Improving Huntington's disease clinical trial recruitment through patient and family education
• Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis
• FDA: further trial needed for Huntexil approval in HD
• Huntexil update: EMA asks for further trial